基因检测
疾病
鉴定(生物学)
遗传数据
医学
临床试验
遗传咨询
预测性试验
生物信息学
临床实习
考试(生物学)
遗传模型
精密医学
遗传倾向
计算生物学
遗传诊断
生物
人类遗传学
亨廷顿病
全基因组关联研究
梅德林
风险评估
遗传分析
发病年龄
作者
Davina J. Hensman Moss,Rhiannon Ireland,Guy Chapman,Rhona MacLeod,Robyn W. Labrum,James M. Polke,Darren G. Monckton,Peter Holmans,EHDN Genetic Modifiers Working group,EHDN Genetic Counselling and Testing Working Group,Thomas H. Massey,Nayana Lahiri
出处
期刊:Journal of Huntington's disease
[IOS Press]
日期:2025-12-23
卷期号:15 (1): 167-178
被引量:2
标识
DOI:10.1177/18796397251391953
摘要
The identification of the repeat expansion which causes Huntington's disease in 1993 soon led to a clinical genetic test for the condition, enabling people at risk to have a test to determine whether they will get the disease. The primary determinant of age at onset in Huntington's disease is CAG repeat length, but in recent years there have been advances in identifying and characterising genetic modifiers which influence age at onset. This has led to the question of whether these data may be applied clinically to improve clinical practice. Here, on behalf of the European Huntington's Disease Network (EHDN) Genetic Testing and EHDN Genetic Modifiers Working Groups, we review the current state of genetic testing for Huntington's disease and consider the personal impact that pre-symptomatic genetic testing has on those that undertake it. We then discuss how genetic information could be used to improve onset prediction clinically, and whether it could be applied in clinical trials stratification. We conclude by proposing short, medium and long-term recommendations to improve the use of genetic data to in clinical practice and clinical trials.
科研通智能强力驱动
Strongly Powered by AbleSci AI